{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:39:24Z","timestamp":1790800764704,"version":"4.1.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      The global aging trend is expected to double the population aged 65 and older by 2050, posing new challenges for healthcare systems. Frailty is associated with poorer prognosis, increased postoperative complications, and reduced treatment tolerance. Accurate frailty assessment (FA) is therefore crucial for diagnosis, risk stratification, and individualized treatment planning. Despite its clinical relevance, clear evidence-based guidance for implementation in gynecologic oncology remains lacking\n                      <jats:bold>.<\/jats:bold>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An anonymous online survey with 51 multiple-choice and open-ended questions was conducted from May to August 2022. It targeted gynecologists and oncologists in Germany, Austria, and Switzerland, and was distributed to 633 healthcare institutions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 112 responses were analyzed, revealing considerable variation in the application of frailty assessments. Only 11% reported routine use, while 36% applied FA selectively. Screening tools varied: 52% used institution-specific forms, while validated instruments such as G8 or VES-13 were rarely used. Timing was inconsistent: 49% performed FA preoperatively, 36% before chemotherapy, 31% at first presentation, and 30% without a fixed timepoint. Prehabilitation programs were largely absent; only 21% of institutions offered them. 77% of respondents indicated a need for further training.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There are substantial gaps in the use of frailty assessments in gynecologic oncology. Standardized procedures, prehabilitation programs, and targeted education are essential to improve care quality and treatment outcomes in the context of an aging patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-025-08129-w","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:05:11Z","timestamp":1753992311000},"page":"1337-1344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The implementation of frailty assessment in gynecologic oncology: an international multicenter JAGO-NOGGO survey"],"prefix":"10.1007","volume":"312","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4429-2840","authenticated-orcid":false,"given":"C.","family":"Flethe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-3605","authenticated-orcid":false,"given":"C.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"von Beckerath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Alavi-Demirci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3348-7877","authenticated-orcid":false,"given":"G.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-0046","authenticated-orcid":false,"given":"M.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2056-1668","authenticated-orcid":false,"given":"K.","family":"Pietzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-6623","authenticated-orcid":false,"given":"J.","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"8129_CR1","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects 2022: Summary of Results. New York: United Nations; 2022. Available from: https:\/\/population.un.org\/wpp\/ Accessed 26 Mar 2025"},{"issue":"10206","key":"8129_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP (2019) Frailty: implications for clinical practice and public health. Lancet 394(10206):1365\u20131375. https:\/\/doi.org\/10.1016\/S0140-6736(19)31786-6","journal-title":"Lancet"},{"issue":"6","key":"8129_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","volume":"26","author":"C Handforth","year":"2015","unstructured":"Handforth C, Clegg A, Young C, Simpkins S, Seymour MT, Selby PJ, Young J (2015) The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol 26(6):1091\u20131101. https:\/\/doi.org\/10.1093\/annonc\/mdu540","journal-title":"Ann Oncol"},{"issue":"4","key":"8129_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.eurger.2015.04.003","volume":"6","author":"G Kolb","year":"2015","unstructured":"Kolb G, Rehmann P, Karbe-Voigt N, W\u00f6stmann B (2015) Are old patients not fit for clinical trials, or do clinical trials not fit to old patients? A survey in 35 pharmaceutical companies. Eur Geriatr Med 6(4):354\u2013357. https:\/\/doi.org\/10.1016\/j.eurger.2015.04.003","journal-title":"Eur Geriatr Med"},{"issue":"4\u20135","key":"8129_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.euf.2017.10.010","volume":"3","author":"C Hernandez Torres","year":"2017","unstructured":"Hernandez Torres C, Hsu T (2017) Comprehensive geriatric assessment in the older adult with cancer: a review. Eur Urol Focus 3(4\u20135):330\u2013339. https:\/\/doi.org\/10.1016\/j.euf.2017.10.010","journal-title":"Eur Urol Focus"},{"issue":"3","key":"8129_CR6","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/ijcp.12313","volume":"68","author":"TJ Welsh","year":"2014","unstructured":"Welsh TJ, Gordon AL, Gladman JR (2014) Comprehensive geriatric assessment - a guide for the non-specialist. Int J Clin Pract 68(3):290\u2013293. https:\/\/doi.org\/10.1111\/ijcp.12313","journal-title":"Int J Clin Pract"},{"issue":"1","key":"8129_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41256-023-00323-0","volume":"8","author":"PAL Seghers","year":"2023","unstructured":"Seghers PAL, Alibhai SMH, Battisti NML, Kanesvaran R, Extermann M, O\u2019Donovan A et al (2023) Geriatric assessment for older people with cancer: policy recommendations. Glob Health Res Policy 8(1):37. https:\/\/doi.org\/10.1186\/s41256-023-00323-0","journal-title":"Glob Health Res Policy"},{"issue":"1","key":"8129_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/SPC.0000000000000635","volume":"17","author":"TR Chesney","year":"2023","unstructured":"Chesney TR, Daza JF, Wong CL (2023) Geriatric assessment and treatment decision-making in surgical oncology. Curr Opin Support Palliat Care 17(1):22\u201330. https:\/\/doi.org\/10.1097\/SPC.0000000000000635","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"8129_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-016-0329-8","volume":"16","author":"HS Lin","year":"2016","unstructured":"Lin HS, Watts JN, Peel NM, Hubbard RE (2016) Frailty and post-operative outcomes in older surgical patients: a systematic review. BMC Geriatr 16(1):157. https:\/\/doi.org\/10.1186\/s12877-016-0329-8","journal-title":"BMC Geriatr"},{"issue":"6","key":"8129_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jgo.2022.04.008","volume":"13","author":"M Hamaker","year":"2022","unstructured":"Hamaker M, Lund C, te Molder M, Soubeyran P, Wildiers H, van Huis L et al (2022) Geriatric assessment in the management of older patients with cancer - a systematic review (update). J Geriatr Oncol 13(6):761\u2013777. https:\/\/doi.org\/10.1016\/j.jgo.2022.04.008","journal-title":"J Geriatr Oncol"},{"issue":"3","key":"8129_CR11","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e16","volume":"35","author":"H Lee","year":"2020","unstructured":"Lee H, Lee E, Jang IY (2020) Frailty and comprehensive geriatric assessment. J Korean Med Sci 35(3):e16. https:\/\/doi.org\/10.3346\/jkms.2020.35.e16","journal-title":"J Korean Med Sci"},{"issue":"4","key":"8129_CR12","first-page":"214","volume":"98","author":"C Kumar","year":"2018","unstructured":"Kumar C, Salzman B, Colburn JL (2018) Preoperative assessment in older adults: a comprehensive approach. Am Fam Physician 98(4):214\u2013220 (PMID: 30215973)","journal-title":"Am Fam Physician"},{"issue":"6","key":"8129_CR13","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s00404-022-06850-4","volume":"307","author":"K Anic","year":"2023","unstructured":"Anic K, Varchola J, Schmidt MW, Schwab R, Linz VC, Schmidt M et al (2023) Influence of interdisciplinary frailty screening on perioperative complication rates in elderly ovarian cancer patients: results of a retrospective observational study. Arch Gynecol Obstet 307(6):1929\u20131940. https:\/\/doi.org\/10.1007\/s00404-022-06850-4","journal-title":"Arch Gynecol Obstet"},{"key":"8129_CR14","unstructured":"German Society for Geriatrics (DGG). S3 guideline: Comprehensive geriatric assessment (CGA) for hospitalized patients. AWMF Registry No.: 084\u2013003. 2024. Available from: https:\/\/register.awmf.org\/assets\/guidelines\/084_D_Ges_fuer_Geriatrie\/084-003fol_S3_Umfassendes-Geriatrisches-Assessment-Comprehensive-Geriatric-Assessment-CGA-bei-hospitalisierten-PatientInnen_2024-06.pdf Accessed 15 Mar 2025"},{"issue":"6","key":"8129_CR15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1200\/OP.20.00442","volume":"17","author":"W Dale","year":"2021","unstructured":"Dale W, Williams GR, MacKenzie AR, Soto-Perez-de-Celis E, Maggiore RJ, Merrill JK et al (2021) How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology. JCO Oncol Pract 17(6):336\u2013344. https:\/\/doi.org\/10.1200\/OP.20.00442","journal-title":"JCO Oncol Pract"},{"issue":"22","key":"8129_CR16","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS et al (2018) Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol 36(22):2326\u20132347. https:\/\/doi.org\/10.1200\/JCO.2018.78.8687","journal-title":"J Clin Oncol"},{"issue":"2","key":"8129_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00404-019-05321-7","volume":"301","author":"S Schneider","year":"2020","unstructured":"Schneider S, Armbrust R, Spies C, du Bois A, Sehouli J (2020) Prehabilitation programs and ERAS protocols in gynecological oncology: a comprehensive review. Arch Gynecol Obstet 301(2):315\u2013326. https:\/\/doi.org\/10.1007\/s00404-019-05321-7","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"8129_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.bja.2021.12.007","volume":"128","author":"C Gillis","year":"2022","unstructured":"Gillis C, Ljungqvist O, Carli F (2022) Prehabilitation, enhanced recovery after surgery, or both? A narrative review. Br J Anaesth 128(3):434\u2013448. https:\/\/doi.org\/10.1016\/j.bja.2021.12.007","journal-title":"Br J Anaesth"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08129-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08129-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:25:50Z","timestamp":1757463950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08129-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["8129"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08129-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7066871\/v1","asserted-by":"object"}]},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"7 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jalid Sehouli reports receiving research support from Roche Pharma, AstraZeneca, Bayer, Clovis Oncology, GlaxoSmithKline, Lilly, Iqvia, Mural, and MSD. He has received honoraria from GlaxoSmithKline, PharmaMar, AstraZeneca, Clovis Oncology, Bayer, Roche Pharma, Vifor Pharma, Hexal AG, Novartis Pharma, Eisai, Esteve Pharmaceuticals, Incyte Biosciences, Phytolife Nutrition, JenaPharm, Kyowa Kirin, Oncoinvent AS, Daiichi, Medtronic Covidien, AMGEN, AbbVie, Corcept Therapeutics, Gilead Sciences, and Myriad. He has served in consulting or advisory roles for Merck\/Pfizer, PharmaMar, Clovis Oncology, AstraZeneca, Roche Pharma, GlaxoSmithKline, MSD, Eisai, Novocure, Oncoinvent, Intuitive Surgical, Seagen, Bayer Vital, Mundipharma, Sanofi-Aventis Deutschland GmbH, Immunogen, Tubulis GmbH, Daiichi Sankyo, Bristol Myers Squibb, Karyopharm Therapeutics, and Corcept Therapeutics. Klaus Pietzner reports receiving honoraria or travel support from AstraZeneca, Roche, Tesaro\/GlaxoSmithKline, MSD Sharp & Dohme, Novartis, Eisai, Immunogen\/AbbVie, and Daiichi Sankyo. He has served in consulting or advisory roles for AstraZeneca, Roche, Tesaro\/GlaxoSmithKline, MSD Sharp & Dohme, Novartis, Eisai, Immunogen\/AbbVie, Daiichi Sankyo, and Myriad. Anne-Karen Beckerath reports receiving travel support in the form of congress registration fees covered by Gideon Richter. Chiara Flethe, Catherine Krause, Sara Alavi-Demirci and Maximilian Beck declare no competing interests to the content of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the ethics committee of Charit\u00e9\u2014Universit\u00e4tsmedizin Berlin (EA1\/134\/21).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Participation in the survey was voluntary and anonymous; therefore, no written informed consent was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}